Anti-SGLT2 抗体 (ab37296)
Key features and details
- Rabbit polyclonal to SGLT2
- Suitable for: WB
- Reacts with: Mouse, Rat, Human
- Isotype: IgG
製品の概要
-
製品名
Anti-SGLT2 antibody
SGLT2 一次抗体 製品一覧 -
製品の詳細
Rabbit polyclonal to SGLT2 -
由来種
Rabbit -
特異性
The antibody detects 74 kDa SGLT-2 from human, mouse, and rat origins. Reactivity to other species has not been determined. A ~55 kDa and a ~45 kDa band can also be detected, representing the SGLT-2 cleavage fragments. -
アプリケーション
適用あり: WBmore details -
種交差性
交差種: Mouse, Rat, Human -
免疫原
Synthetic peptide corresponding to Mouse SGLT2 (N terminal).
Database link: Q923I7 -
ポジティブ・コントロール
- WB: Jurkat, NIH3T3, PC12
-
特記事項
This product is manufactured by BioVision, an Abcam company and was previously called 3690 SGLT-2 Antibody. 3690-100 is the same size as the 100 µg size of ab37296.
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
製品の特性
-
製品の状態
Liquid -
保存方法
Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles. -
バッファー
Preservative: 0.02% Thimerosal (merthiolate)
Constituents: 1% BSA, 50% Glycerol (glycerin, glycerine), PBS -
Concentration information loading...
-
精製度
Protein A purified -
ポリ/モノ
ポリクローナル -
アイソタイプ
IgG -
研究分野
関連製品
-
Compatible Secondaries
-
Isotype control
-
Recombinant Protein
アプリケーション
The Abpromise guarantee
Abpromise保証は、 次のテスト済みアプリケーションにおけるab37296の使用に適用されます
アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。
アプリケーション | Abreviews | 特記事項 |
---|---|---|
WB | (8) |
Use a concentration of 1 µg/ml. Predicted molecular weight: 73 kDa.
|
特記事項 |
---|
WB
Use a concentration of 1 µg/ml. Predicted molecular weight: 73 kDa. |
ターゲット情報
-
機能
Sodium-dependent glucose transporter. Has a Na(+) to glucose coupling ratio of 1:1.
Efficient substrate transport in mammalian kidney is provided by the concerted action of a low affinity high capacity and a high affinity low capacity Na(+)/glucose cotransporter arranged in series along kidney proximal tubules. -
関連疾患
Defects in SLC5A2 are the cause of renal glucosuria (GLYS1) [MIM:233100]. GLYS1 is an autosomal recessive disorder characterized by a normal fasting serum glucose concentration and persistent isolated glucosuria, with a normal glucose tolerance test. -
配列類似性
Belongs to the sodium:solute symporter (SSF) (TC 2.A.21) family. -
細胞内局在
Membrane. - Information by UniProt
-
参照データベース
- Entrez Gene: 6524 Human
- Entrez Gene: 246787 Mouse
- Entrez Gene: 64522 Rat
- Omim: 182381 Human
- SwissProt: P31639 Human
- SwissProt: Q923I7 Mouse
- SwissProt: P53792 Rat
- Unigene: 709195 Human
see all -
別名
- Low affinity sodium glucose cotransporter antibody
- Low affinity sodium-glucose cotransporter antibody
- Na(+) glucose cotransporter 2 antibody
see all
画像
プロトコール
データシートおよび資料
-
SDS download
-
Datasheet download
参考文献 (34)
ab37296 は 34 報の論文で使用されています。
- Korfhage J et al. Canagliflozin Increases Intestinal Adenoma Burden in Female ApcMin/+ Mice. J Gerontol A Biol Sci Med Sci 77:215-220 (2022). PubMed: 34448851
- Xu Z et al. Canagliflozin Ameliorates Nonalcoholic Fatty Liver Disease by Regulating Lipid Metabolism and Inhibiting Inflammation through Induction of Autophagy. Yonsei Med J 63:619-631 (2022). PubMed: 35748073
- Li SR et al. Glucose absorption drives cystogenesis in a human organoid-on-chip model of polycystic kidney disease. Nat Commun 13:7918 (2022). PubMed: 36564419
- Bernhardt A et al. High salt diet-induced proximal tubular phenotypic changes and sodium-glucose cotransporter-2 expression are coordinated by cold shock Y-box binding protein-1. FASEB J 35:e21912 (2021). PubMed: 34533842
- Liu SH et al. Chitosan Oligosaccharide Alleviates Abnormal Glucose Metabolism without Inhibition of Hepatic Lipid Accumulation in a High-Fat Diet/Streptozotocin-Induced Diabetic Rat Model. Mar Drugs 19:N/A (2021). PubMed: 34201848